Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease

Kardiologiia

Volumn 47, Issue 4, 2007, Pages 37-40

  Pirkova, A A ^a   Samoilova E V ^a   Ameliushkina, V A ^a   Kaminnyi A I ^a   Titov, V N ^a   Prokazova, N V ^a   Naumov, V G ^a   Kucharchuk, V V ^a   Korotaeva, A A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2 GROUP II; PLA2G2A PROTEIN, HUMAN; PYRROLE DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; GROUP II PHOSPHOLIPASES A2; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LECITHINS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PYRROLES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 40149083936     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)